BIOAF: Collaboration Arrangement with Janssen
By John Vandermosten, CFA
OTC:BIOAF
READ THE FULL BIOAF RESEARCH REPORT
Bioasis Enters Into Research Collaboration With Johnson & Jonson’s Janssen; Terms Not Disclosed
BIOASIS TECHNOLOGIES INC. (TSXV:BTI, OTCQB:BIOAF), (the "Company or "Bioasis"), a biopharmaceutical company developing its proprietary xB3TM platform technology for the delivery of therapeutics
BIOAF: Third Quarter Results
By John Vandermosten, CFA
OTC:BIOAF
READ THE FULL BIOAF RESEARCH REPORT
BIOAF: Second Quarter Update
By John Vandermosten, CFA
OTC:BIOAF
READ THE FULL BIOAF RESEARCH REPORT
BIOAF: New Funding & Research Collaborations Expand xB3 Opportunities
By John Vandermosten, CFA
OTC:BIOAF
READ THE FULL BIOAF RESEARCH REPORT
BIOAF: New Funds and Collaborators
By John Vandermosten, CFA
OTC:BIOAF
READ THE FULL BIOAF RESEARCH REPORT